Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10371 |
| Vaccine Name | Simplirix |
| Disease Name | Genital Herpes |
| Disease Classification | Cutaneous |
| Virus Name | Herpes simplex virus |
| Nucleic Acid Content | double stranded DNA |
| Vaccine Type | Subunit vaccine |
| Vaccine Status | Phase 3 |
| Manufacturer | GlaxoSmithKline |
| Year of Manufacturing | 2008 |
| Manufacturing Country | UK |
| Age | 18 - 30 years |
| Dosage | NA |
| Administration Route | Intraperitoneal |
| Adjuvant | 3-deacylated form of MPL, alum |
| Target Strain | Herpes simplex virus 2 glycoprotein D (gD-2) |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | National Institute of Allergy and Infectious Diseases |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT00057330 |
| Reference Link | https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates, https://clinicaltrials.gov/ct2/show/NCT00057330 |
| Additional Links | NA |